We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 247.00 | 246.50 | 247.00 | 249.00 | 246.50 | 248.50 | 268,774 | 16:16:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.54 | 998.2M |
TIDMSPI TIDM42SB
RNS Number : 1305V
Spire Healthcare Group PLC
25 January 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or the underlying issuer Spire Healthcare Group of existing shares to which plc voting rights are attached: (ii) --------------------------------------------------------------- --------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------------------------ ------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------ ------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------ ------------------------------ An event changing the breakdown of voting rights ------------------------------------------------------------------ ------------------------------ Other (please specify): ----------------------------------------------------------- ----- ------------------------------ 3. Full name of person(s) The Goldman Sachs Group, Inc. subject to the notification obligation: (iii) ------------------------------------------------------------- ----------------------------------- 4. Full name of shareholder(s) Goldman Sachs International (if different from 3.):(iv) GS Investment Strategies, LLC ------------------------------------------------------------- ----------------------------------- 5. Date of the transaction 20 January 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- ----------------------------------- 6. Date on which issuer 24 January 2017 notified: ------------------------------------------------------------- ----------------------------------- 7. Threshold(s) that is/are Below 3% crossed or reached: (vi, vii) ------------------------------------------------------------- ----------------------------------- 8. Notified details: ------------------------------------------------------------------------------------------------------------ A: Voting rights attached to shares (viii, ix) ------------------------------------------------------------------------------------------------------------ Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ---------------- ------------------------------ ---------------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights ---------------- -------------- -------------- -------- ----------------------- ----------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ---------------- -------------- -------------- -------- ------- -------------- ------- -------------- Below Below GB00BNLPYF73 6,939,247 6,939,247 3% 3% -------------- -------------- -------- ------- -------------- ------- -------------- B: Qualifying Financial Instruments ------------------------------------------------------------------------------------------------------------ Resulting situation after the triggering transaction ------------------------------------------------------------------------------------------------------------ Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ---------------- -------------- ------------------------ ----------------------- ----------------------- Below 3% Below 3% ---------------- -------------- ------------------------ ----------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument period refers to xx) ------------ --------- ----------- ------------ ------------------ ---------------- Nominal Delta ------------ --------- ----------- ------------ ------------------ -------- ------ ------------------------------------------------------------------------------------------------------------ Total (A+B+C) ------------------------------------------------------------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------------------------------ ---------------------------------------------------------- Below 3% Below 3% ------------------------------------------------ ---------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------------- N/A Proxy Voting: ---------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------- ------------------------------- 11. Number of voting rights proxy N/A holder will cease to hold: ------------------------------------------------------- ------------------------------- 12. Date on which proxy holder will N/A cease to hold voting rights: ------------------------------------------------------- ------------------------------- General email contact: 13. Additional information: shareholderdisclosures@gs.com ------------------------------------------------------- ------------------------------- 14. Contact name: Joanna Foley ------------------------------------------------------- ------------------------------- 15. Contact telephone number: +44 207 051 9996 ------------------------------------------------------- -------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVVVRBKAAUAR
(END) Dow Jones Newswires
January 25, 2017 11:01 ET (16:01 GMT)
1 Year Spire Healthcare Chart |
1 Month Spire Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions